Supporting Complex Biologics with Flexible Solutions
BIOLOGICAL PHARMA CENTER is a dynamic contract development and manufacturing organization (CDMO) in…
Join hands with professional investors to build a leading company in the pharmaceutical CDMO field
Ziqiang Zeng, Managing partner at Huagai Capital Medical Fund
International services to achieve dual registration in China and the US
As a domestic CDMO service provider with a CGMP production site in…
Provide cell lines with intellectual property to alleviate industry bottlenecks
Facing the increasingly strict environment for the regulatory approval of new drugs,…
Leverage BIOLOGICAL PHARMA CENTER brand advantages to provide one-stop service for the biopharmaceutical industry
By leveraging BIOLOGICAL PHARMA CENTER Labs brand and customer resources, BIOLOGICAL PHARMA CENTER Bio provides comprehensive…
BIOLOGICAL PHARMA CENTER Bio Announcement
BIOLOGICAL PHARMA CENTER Inc. receives US $60 Million Series A financing led by…
BioProcess International Conference
BIOLOGICAL PHARMA CENTER gave an oral presentation regarding Case Study of Antibody Developability…
CABS 2019
BIOLOGICAL PHARMA CENTER was invited to a panel discussion of “Innovative and Collaborative…
Cell Line Development and Engineering Conference
BIOLOGICAL PHARMA CENTER presented a poster regarding cell line development at the Cell…
Pegs Boston
BIOLOGICAL PHARMA CENTER presented a poster regarding developability assessment at PEGS the Essential…